Ropes & Gray Represents Bain Capital in Sale of Feixiang Chemicals to Rhodia S.A.
Ropes & Gray has represented Bain Capital in the US $489 million sale of Feixiang Chemicals (Zhangjiagang) Co., Ltd., a PRC-based specialty chemical manufacturer, to Rhodia S.A. The transaction received PRC governmental approval and closed Nov. 30.
The deal is the latest high-profile private equity transaction handled by Ropes & Gray in Hong Kong. In October, Hong Kong-based teams of Ropes & Gray attorneys represented TPG in its investment in China Vogue Casualwear, a Shishi, China-based distributor and retailer of casual wear under the brand name Sisulan, and the NYSE IPO of ShangPharma, a TPG portfolio company based in Shanghai that provides chemistry resource outsourcing services to global pharmaceutical and biotech companies.
With one of the leading private equity practices in the world, Ropes & Gray’s lawyers have been involved in some of the most significant private equity deals of 2010, including representing TPG it its $3 billion acquisition of J.Crew Group, Inc.; Bain Capital in its $1.8 billion acquisition of Gymboree Corporation; a private equity consortium consisting of Berkshire Partners, Bain Capital and Advent International in the $1.1 billion leveraged buyout of SkillSoft; TPG in a co-investment with Goldman Sachs for the €1.2 billion secondary buyout acquisition of Ontex N.V.; and Thomas H. Lee Partners in its $1.1 billion acquisition of inVentiv Health.